Indication

Acquired Methaemoglobinaemia

1 clinical trial

1 product

Clinical trial

Open Label Clinical Study to Evaluate the Safety and Efficacy of ProvayBlueTM (Methylene Blue) for the Treatment of Acquired Methemoglobinemia

Status: Completed, Estimated PCD: 2020-08-31

Product